US
Patent Prosecution
Patent Strategy & Management
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Gagala, Bruce | Intellectual Property | Hatch-Waxman Patent Litigation, Patent Prosecution, General Patent Litigation | Chicago |
| Hasan, Salim | Intellectual Property | Patent Strategy & Management, General Patent Litigation | Chicago |
| Kilyk, John | Intellectual Property | Hatch-Waxman Patent Litigation, Patent Prosecution, Patent Strategy & Management, General Patent Litigation | Chicago |
| Sklar, Steven | Intellectual Property | Hatch-Waxman Patent Litigation, Patent Strategy & Management | Chicago |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Leydig Voit & Mayer
Chicago-based IP firm Leydig Voit & Mayer receives national rankings for its expertise in life sciences patent prosecution and strategy. In addition to the firm's non-contentious practice, it is also notable for pharmaceutical and biotech litigation.
John Kilyk and Bruce Gagala are well-versed in both patent litigation and strategic counseling for clients almost exclusively in the life sciences industry. Both were involved in a recent biosimilars dispute for client Samsung Bioepis against Janssen. The suit was eventually dropped, and the client moved to market a biosimilar version of Janssen's Remicade product.
Salim Hasan continues to advise corporations, research institutions and universities in life sciences patent matters. He brings more than 25 years of experience to his practice. Steven Sklar was recently active in multiple Hatch-Waxman disputes for clients seeking to market generic pharmaceutical products.